Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.58 USD
Change Today -0.0206 / -1.29%
Volume 2.0K
As of 1:07 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John B. Landis Ph.D.

Chairman and Member of Compensation & Incentive Stock Option Committee, Bioanalytical Systems Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. John B. Landis, Ph.D. served as Scientific Advisor of NanoMed Pharmaceuticals Inc. Dr. Landis has over 30 years of leadership experience in pharmaceutical research and development. He served as Senior Vice President for Analytical, Chemical, Pharmaceutical and Biotechnology of Schering-Plough Corporation. Dr. Landis served in various management positions with Pharmacia Corporation and The Upjohn Company, including Director of Quality Control, Executive Director of ...

Read Full Background

Corporate Headquarters*

Purdue Research Park
West Lafayette, Indiana 47906

United States

Phone: 765-463-4527
Fax: 765-497-1102

Board Members Memberships*

Chairman and Member of Compensation & Incentive Stock Option Committee


Purdue University
Purdue University
Master's Degree
Purdue University
Bachelor's Degree
Kent State University
Kent State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$6,093
Total Calculated Compensation$6,093
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BASI:US $1.58 USD -0.0206


James C. Foster J.D.Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Charles River Laboratories International, Inc.
Thomas H. Pike Chief Executive Officer and Director
Quintiles Transnational Holdings Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOANALYTICAL SYSTEMS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at